JP2010531298A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010531298A5 JP2010531298A5 JP2010512189A JP2010512189A JP2010531298A5 JP 2010531298 A5 JP2010531298 A5 JP 2010531298A5 JP 2010512189 A JP2010512189 A JP 2010512189A JP 2010512189 A JP2010512189 A JP 2010512189A JP 2010531298 A5 JP2010531298 A5 JP 2010531298A5
- Authority
- JP
- Japan
- Prior art keywords
- formulation
- pain
- formulation according
- item
- fatty acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 claims description 58
- 238000009472 formulation Methods 0.000 claims description 52
- 208000002193 Pain Diseases 0.000 claims description 29
- -1 fatty acid ester Chemical class 0.000 claims description 20
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 13
- 239000000194 fatty acid Substances 0.000 claims description 13
- 229930195729 fatty acid Natural products 0.000 claims description 13
- 239000000499 gel Substances 0.000 claims description 11
- 230000000699 topical effect Effects 0.000 claims description 11
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 7
- 239000006071 cream Substances 0.000 claims description 7
- 239000006185 dispersion Substances 0.000 claims description 7
- 239000006260 foam Substances 0.000 claims description 7
- 239000000787 lecithin Substances 0.000 claims description 7
- 229940067606 lecithin Drugs 0.000 claims description 7
- 235000010445 lecithin Nutrition 0.000 claims description 7
- 239000006210 lotion Substances 0.000 claims description 7
- 239000002674 ointment Substances 0.000 claims description 7
- 239000006072 paste Substances 0.000 claims description 7
- 239000007921 spray Substances 0.000 claims description 7
- 239000000725 suspension Substances 0.000 claims description 7
- 229930182558 Sterol Natural products 0.000 claims description 6
- 239000004480 active ingredient Substances 0.000 claims description 6
- 150000002632 lipids Chemical class 0.000 claims description 6
- 210000003205 muscle Anatomy 0.000 claims description 6
- 239000003961 penetration enhancing agent Substances 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 6
- 150000003432 sterols Chemical class 0.000 claims description 6
- 235000003702 sterols Nutrition 0.000 claims description 6
- 229920000742 Cotton Polymers 0.000 claims description 4
- 230000036528 appetite Effects 0.000 claims description 4
- 235000019789 appetite Nutrition 0.000 claims description 4
- 230000029058 respiratory gaseous exchange Effects 0.000 claims description 4
- 210000002435 tendon Anatomy 0.000 claims description 4
- 208000006820 Arthralgia Diseases 0.000 claims description 3
- 230000007883 bronchodilation Effects 0.000 claims description 3
- 239000004744 fabric Substances 0.000 claims description 3
- 208000024891 symptom Diseases 0.000 claims description 3
- 208000000094 Chronic Pain Diseases 0.000 claims description 2
- 206010019233 Headaches Diseases 0.000 claims description 2
- 206010065390 Inflammatory pain Diseases 0.000 claims description 2
- 208000001294 Nociceptive Pain Diseases 0.000 claims description 2
- 208000037656 Respiratory Sounds Diseases 0.000 claims description 2
- 206010047924 Wheezing Diseases 0.000 claims description 2
- 230000001154 acute effect Effects 0.000 claims description 2
- 208000005298 acute pain Diseases 0.000 claims description 2
- 239000000853 adhesive Substances 0.000 claims description 2
- 230000001070 adhesive effect Effects 0.000 claims description 2
- 239000002390 adhesive tape Substances 0.000 claims description 2
- 229920001577 copolymer Polymers 0.000 claims description 2
- 239000003814 drug Substances 0.000 claims description 2
- 229940079593 drug Drugs 0.000 claims description 2
- 239000000835 fiber Substances 0.000 claims description 2
- 231100000869 headache Toxicity 0.000 claims description 2
- 210000001503 joint Anatomy 0.000 claims description 2
- 239000007934 lip balm Substances 0.000 claims description 2
- 239000000463 material Substances 0.000 claims description 2
- 201000008482 osteoarthritis Diseases 0.000 claims description 2
- 239000011505 plaster Substances 0.000 claims description 2
- 229920000233 poly(alkylene oxides) Polymers 0.000 claims description 2
- 229920000642 polymer Polymers 0.000 claims description 2
- 210000001519 tissue Anatomy 0.000 claims description 2
- 208000009935 visceral pain Diseases 0.000 claims description 2
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 claims 5
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 claims 4
- 239000000546 pharmaceutical excipient Substances 0.000 claims 4
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims 2
- 206010006811 Bursitis Diseases 0.000 claims 2
- 206010052904 Musculoskeletal stiffness Diseases 0.000 claims 2
- 208000023835 Tendon disease Diseases 0.000 claims 2
- 239000003995 emulsifying agent Substances 0.000 claims 2
- PZNPLUBHRSSFHT-RRHRGVEJSA-N 1-hexadecanoyl-2-octadecanoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCCCC(=O)O[C@@H](COP([O-])(=O)OCC[N+](C)(C)C)COC(=O)CCCCCCCCCCCCCCC PZNPLUBHRSSFHT-RRHRGVEJSA-N 0.000 claims 1
- 241000254032 Acrididae Species 0.000 claims 1
- 208000036487 Arthropathies Diseases 0.000 claims 1
- 241000196324 Embryophyta Species 0.000 claims 1
- 208000012659 Joint disease Diseases 0.000 claims 1
- 208000012902 Nervous system disease Diseases 0.000 claims 1
- 208000025966 Neurological disease Diseases 0.000 claims 1
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical group C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 claims 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims 1
- 229920002701 Polyoxyl 40 Stearate Polymers 0.000 claims 1
- 229920001214 Polysorbate 60 Polymers 0.000 claims 1
- 235000021355 Stearic acid Nutrition 0.000 claims 1
- 150000005215 alkyl ethers Chemical class 0.000 claims 1
- 230000003247 decreasing effect Effects 0.000 claims 1
- YQEMORVAKMFKLG-UHFFFAOYSA-N glycerine monostearate Natural products CCCCCCCCCCCCCCCCCC(=O)OC(CO)CO YQEMORVAKMFKLG-UHFFFAOYSA-N 0.000 claims 1
- SVUQHVRAGMNPLW-UHFFFAOYSA-N glycerol monostearate Natural products CCCCCCCCCCCCCCCCC(=O)OCC(O)CO SVUQHVRAGMNPLW-UHFFFAOYSA-N 0.000 claims 1
- 230000002757 inflammatory effect Effects 0.000 claims 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims 1
- 229920001983 poloxamer Polymers 0.000 claims 1
- 229960000502 poloxamer Drugs 0.000 claims 1
- 229940099429 polyoxyl 40 stearate Drugs 0.000 claims 1
- 208000023504 respiratory system disease Diseases 0.000 claims 1
- 239000008347 soybean phospholipid Substances 0.000 claims 1
- 239000008117 stearic acid Substances 0.000 claims 1
- 238000000034 method Methods 0.000 description 12
- 239000001993 wax Substances 0.000 description 4
- 239000003623 enhancer Substances 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- 239000004166 Lanolin Substances 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 206010066371 Tendon pain Diseases 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 208000013465 muscle pain Diseases 0.000 description 1
- 201000001119 neuropathy Diseases 0.000 description 1
- 230000007823 neuropathy Effects 0.000 description 1
- 208000001797 obstructive sleep apnea Diseases 0.000 description 1
- 208000033808 peripheral neuropathy Diseases 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US94355207P | 2007-06-12 | 2007-06-12 | |
| US11/851,241 US9511016B2 (en) | 2007-06-12 | 2007-09-06 | Topical composition for treating pain |
| PCT/US2008/007354 WO2008156646A1 (en) | 2007-06-12 | 2008-06-11 | Topical composition for treating pain |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010531298A JP2010531298A (ja) | 2010-09-24 |
| JP2010531298A5 true JP2010531298A5 (cg-RX-API-DMAC7.html) | 2012-07-12 |
Family
ID=40132558
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010512189A Pending JP2010531298A (ja) | 2007-06-12 | 2008-06-11 | 疼痛を治療するための局所用組成物 |
Country Status (6)
| Country | Link |
|---|---|
| US (4) | US9511016B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2164476A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2010531298A (cg-RX-API-DMAC7.html) |
| CN (1) | CN101842090A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2008266971B2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2008156646A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (92)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8512718B2 (en) | 2000-07-03 | 2013-08-20 | Foamix Ltd. | Pharmaceutical composition for topical application |
| IL152486A0 (en) | 2002-10-25 | 2003-05-29 | Meir Eini | Alcohol-free cosmetic and pharmaceutical foam carrier |
| US9265725B2 (en) | 2002-10-25 | 2016-02-23 | Foamix Pharmaceuticals Ltd. | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
| US20080138296A1 (en) | 2002-10-25 | 2008-06-12 | Foamix Ltd. | Foam prepared from nanoemulsions and uses |
| US9668972B2 (en) | 2002-10-25 | 2017-06-06 | Foamix Pharmaceuticals Ltd. | Nonsteroidal immunomodulating kit and composition and uses thereof |
| US9211259B2 (en) | 2002-11-29 | 2015-12-15 | Foamix Pharmaceuticals Ltd. | Antibiotic kit and composition and uses thereof |
| US7704518B2 (en) | 2003-08-04 | 2010-04-27 | Foamix, Ltd. | Foamable vehicle and pharmaceutical compositions thereof |
| US7700076B2 (en) | 2002-10-25 | 2010-04-20 | Foamix, Ltd. | Penetrating pharmaceutical foam |
| US8119150B2 (en) | 2002-10-25 | 2012-02-21 | Foamix Ltd. | Non-flammable insecticide composition and uses thereof |
| US10117812B2 (en) | 2002-10-25 | 2018-11-06 | Foamix Pharmaceuticals Ltd. | Foamable composition combining a polar solvent and a hydrophobic carrier |
| CA2502986C (en) | 2002-10-25 | 2011-08-23 | Foamix Ltd. | Cosmetic and pharmaceutical foam |
| US7820145B2 (en) | 2003-08-04 | 2010-10-26 | Foamix Ltd. | Oleaginous pharmaceutical and cosmetic foam |
| US8900554B2 (en) | 2002-10-25 | 2014-12-02 | Foamix Pharmaceuticals Ltd. | Foamable composition and uses thereof |
| US8119109B2 (en) | 2002-10-25 | 2012-02-21 | Foamix Ltd. | Foamable compositions, kits and methods for hyperhidrosis |
| US8486376B2 (en) | 2002-10-25 | 2013-07-16 | Foamix Ltd. | Moisturizing foam containing lanolin |
| US7575739B2 (en) | 2003-04-28 | 2009-08-18 | Foamix Ltd. | Foamable iodine composition |
| US8795693B2 (en) | 2003-08-04 | 2014-08-05 | Foamix Ltd. | Compositions with modulating agents |
| US8486374B2 (en) | 2003-08-04 | 2013-07-16 | Foamix Ltd. | Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses |
| US20050271746A1 (en) * | 2004-05-18 | 2005-12-08 | Abbott Chun L | Topical treatments for abnormal biological conditions and method of topically treating such conditions |
| US9486408B2 (en) | 2005-12-01 | 2016-11-08 | University Of Massachusetts Lowell | Botulinum nanoemulsions |
| US20080260655A1 (en) | 2006-11-14 | 2008-10-23 | Dov Tamarkin | Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses |
| US9511016B2 (en) * | 2007-06-12 | 2016-12-06 | Epicentrx, Inc. | Topical composition for treating pain |
| US8636982B2 (en) | 2007-08-07 | 2014-01-28 | Foamix Ltd. | Wax foamable vehicle and pharmaceutical compositions thereof |
| US20090130048A1 (en) * | 2007-11-19 | 2009-05-21 | Oronsky Bryan Todd | Topical Composition for Treating Pain |
| US8784872B2 (en) | 2007-11-19 | 2014-07-22 | Comgenrx, Inc. | Formulation for decreasing tobacco, alcohol, drug or food consumption |
| WO2009069006A2 (en) | 2007-11-30 | 2009-06-04 | Foamix Ltd. | Foam containing benzoyl peroxide |
| WO2009090495A2 (en) | 2007-12-07 | 2009-07-23 | Foamix Ltd. | Oil and liquid silicone foamable carriers and formulations |
| WO2010041141A2 (en) | 2008-10-07 | 2010-04-15 | Foamix Ltd. | Oil-based foamable carriers and formulations |
| AU2009205314A1 (en) | 2008-01-14 | 2009-07-23 | Foamix Ltd. | Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses |
| US20090188521A1 (en) * | 2008-01-17 | 2009-07-30 | Evazynajad Ali M | Dental Floss Formed from Botanic and Botanically Derived Fiber |
| US20100104614A1 (en) * | 2008-06-27 | 2010-04-29 | Oronsky Bryan T | Providone compositions for wound healing |
| KR20180038574A (ko) | 2008-07-18 | 2018-04-16 | 바이오모드 컨셉츠 인코포레이티드 | 활성 성분을 방출하는 제품 |
| WO2010125470A2 (en) | 2009-04-28 | 2010-11-04 | Foamix Ltd. | Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof |
| US20120053134A1 (en) * | 2009-05-07 | 2012-03-01 | Jae-Hoon Jung | Pharmaceutical composition for preventing or treating neuronal damage and neurological diseases |
| WO2011013008A2 (en) | 2009-07-29 | 2011-02-03 | Foamix Ltd. | Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses |
| WO2011013009A2 (en) | 2009-07-29 | 2011-02-03 | Foamix Ltd. | Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses |
| AU2010283998B2 (en) | 2009-08-21 | 2015-01-29 | Targeted Delivery Technologies Limited | Vesicular formulations |
| US8871184B2 (en) | 2009-10-02 | 2014-10-28 | Foamix Ltd. | Topical tetracycline compositions |
| US9849142B2 (en) | 2009-10-02 | 2017-12-26 | Foamix Pharmaceuticals Ltd. | Methods for accelerated return of skin integrity and for the treatment of impetigo |
| US8894630B2 (en) | 2009-11-13 | 2014-11-25 | The Invention Science Fund I, Llc | Device, system, and method for targeted delivery of anti-inflammatory medicaments to a mammalian subject |
| US8439896B2 (en) * | 2009-11-13 | 2013-05-14 | The Invention Science Fund I, Llc | Device, system, and method for targeted delivery of anti-inflammatory medicaments to a mammalian subject |
| US8784368B2 (en) * | 2009-11-13 | 2014-07-22 | The Invention Science Fund I, Llc | Device, system, and method for targeted delivery of anti-inflammatory medicaments to a mammalian subject |
| US8174881B2 (en) | 2009-11-24 | 2012-05-08 | Micron Technology, Inc. | Techniques for reducing disturbance in a semiconductor device |
| US20130165468A1 (en) * | 2010-05-13 | 2013-06-27 | Afgin Pharma, Llc | Topical peripheral neuro-affective (tpna) therapy |
| CN102021824B (zh) * | 2010-11-17 | 2011-12-07 | 南通醋酸纤维有限公司 | 一种纺丝油剂用抑菌型乳化剂 |
| CA2819512C (en) * | 2010-12-01 | 2020-09-29 | Brandie Gowey | Novel topical composition of sarracenia purpurea (pitcher plant) |
| US10744151B1 (en) | 2010-12-01 | 2020-08-18 | Gowey Research Group PLLC | Micro-RNA profiling, compositions, and methods of treating diseases |
| US10758578B2 (en) | 2010-12-01 | 2020-09-01 | Gowey Research Group PLLC | Herbal formulations of carnivorous plants and methods for treating inflammation |
| US11414663B2 (en) | 2010-12-01 | 2022-08-16 | Gowey Research Group, Pllc | Micro-RNA profiling, compositions, and methods of treating diseases |
| US12318420B2 (en) | 2010-12-01 | 2025-06-03 | Gowey Research Group, Pllc | Herbal formulations of carnivorous plants and methods for treating inflammation |
| US11344505B1 (en) | 2010-12-01 | 2022-05-31 | Gowey Research Group, Pllc | Herbal formulations of carnivorous plants and methods for treating inflammation |
| KR20140003572A (ko) * | 2011-01-24 | 2014-01-09 | 안테리오스, 인코퍼레이티드 | 나노입자 조성물 |
| AU2012217858A1 (en) * | 2011-02-15 | 2013-09-05 | Allergan, Inc. | Pharmaceutical cream compositions of oxymetazoline for treating symptoms of rosacea |
| EP2578190A1 (en) * | 2011-10-07 | 2013-04-10 | Sanofi-Aventis Deutschland GmbH | Intraocular injection device |
| US20130190277A1 (en) * | 2012-01-25 | 2013-07-25 | Joel Bain HERRON | Paraffin Wax Embedded Drug Delivery System |
| GB201205642D0 (en) | 2012-03-29 | 2012-05-16 | Sequessome Technology Holdings Ltd | Vesicular formulations |
| CN105209084B (zh) | 2013-03-13 | 2018-07-03 | 艾利丹尼森公司 | 改善的粘合性能 |
| US11083750B2 (en) | 2013-03-15 | 2021-08-10 | Cda Research Group, Inc. | Methods of treatment using topical copper ion formulations |
| US10398733B2 (en) | 2013-03-15 | 2019-09-03 | Cda Research Group, Inc. | Topical copper ion treatments and methods of treatment using topical copper ion treatments in the dermatological areas of the body |
| US11318089B2 (en) | 2013-03-15 | 2022-05-03 | Cda Research Group, Inc. | Topical copper ion treatments and methods of making topical copper ion treatments for use in various anatomical areas of the body |
| US11000545B2 (en) | 2013-03-15 | 2021-05-11 | Cda Research Group, Inc. | Copper ion compositions and methods of treatment for conditions caused by coronavirus and influenza |
| US11007143B2 (en) | 2013-03-15 | 2021-05-18 | Cda Research Group, Inc. | Topical copper ion treatments and methods of treatment using topical copper ion treatments in the oral-respiratory-otic areas of the body |
| US12318406B2 (en) * | 2013-03-15 | 2025-06-03 | Cda Research Group, Inc. | Methods of treatment using topical copper ion formulations |
| WO2015164658A1 (en) * | 2014-04-24 | 2015-10-29 | Sympara Medical, Inc. | Methods and devices for treating hypertension |
| US10653738B2 (en) * | 2014-07-22 | 2020-05-19 | Meridian Research and Development Inc. | Topical medications for bruises and burns |
| CN104491326A (zh) * | 2014-12-09 | 2015-04-08 | 郑志保 | 一种用于推拿治疗腰椎间盘突出症的中药 |
| HK1243330A1 (zh) * | 2014-12-22 | 2018-07-13 | 久光制药株式会社 | 泥罨剂 |
| CN104491228A (zh) * | 2015-01-04 | 2015-04-08 | 杨茹芹 | 一种治疗肾阳衰惫型癃闭的中药组合物 |
| AU2016219974A1 (en) * | 2015-02-18 | 2017-09-07 | Tersus Life Sciences, LLC | Methods for improving joint function |
| CN104825808A (zh) * | 2015-04-23 | 2015-08-12 | 张莉 | 一种治疗慢性咽炎的中药组合物及其制备方法 |
| CN104784502A (zh) * | 2015-05-13 | 2015-07-22 | 戴惠英 | 一种治疗高脂血症的药剂 |
| US10744090B2 (en) | 2015-06-30 | 2020-08-18 | Sequessome Technology Holdings Limited | Multiphasic compositions |
| WO2017027707A1 (en) * | 2015-08-13 | 2017-02-16 | Sense Technology, Inc. | Neurochemical lotion to support manual therapy |
| US10286095B2 (en) | 2015-09-11 | 2019-05-14 | Olson Ip Technologies, Inc. | Travel kit |
| KR20190040931A (ko) | 2016-01-11 | 2019-04-19 | 에피센트알엑스, 인코포레이티드 | 2-브로모-1-(3,3-디니트로아제티딘-1-일)에타논의 정맥내 투여를 위한 조성물 및 방법 |
| CN105559157B (zh) * | 2016-01-25 | 2017-06-30 | 邱定武 | 一种治疗趾腱筋膜炎的袜底及其制备工艺 |
| CN105686100B (zh) * | 2016-01-25 | 2017-08-01 | 邱定武 | 一种治疗足跟痛的袜底及其制备工艺 |
| MX2020012139A (es) | 2016-09-08 | 2021-01-29 | Vyne Pharmaceuticals Inc | Composiciones y metodos para tratar rosacea y acne. |
| US11260035B2 (en) * | 2016-10-12 | 2022-03-01 | Ps Therapies Ltd | Topical compositions and methods of use thereof |
| CA3044219A1 (en) | 2016-11-21 | 2018-05-24 | Eirion Therapeutics, Inc. | Transdermal delivery of large agents |
| US11510901B2 (en) | 2018-01-08 | 2022-11-29 | Epicentrx, Inc. | Methods and compositions utilizing RRx-001 combination therapy for radioprotection |
| US20200345689A1 (en) * | 2018-01-08 | 2020-11-05 | Epicentrx, Inc. | METHODS AND COMPOSITIONS UTILIZING RRx-001 FOR RADIOPROTECTION |
| US10279176B1 (en) * | 2018-06-11 | 2019-05-07 | First Step Holdings, Llc | Method and apparatus for increasing absorption of medications and cosmeceuticals through the skin of the user |
| US11193184B2 (en) | 2019-02-22 | 2021-12-07 | Cda Research Group, Inc. | System for use in producing a metal ion suspension and process of using same |
| CN109999353A (zh) * | 2019-04-19 | 2019-07-12 | 广东泰宝医疗科技股份有限公司 | 一种远红外温感理疗贴及其制备方法 |
| CN118286372A (zh) * | 2019-08-23 | 2024-07-05 | 太康海恩药业有限公司 | 祛风散寒热敷包、组合物及其加工方法 |
| US12138414B2 (en) | 2020-02-10 | 2024-11-12 | Icy Beauty Inc. | Mask assembly for face |
| EP3967308A1 (en) * | 2020-09-11 | 2022-03-16 | Assistance Publique, Hopitaux De Paris | Mepyramine for use in the topical treatment of neuropathic pain |
| US12285541B2 (en) | 2023-01-26 | 2025-04-29 | Insignia Pharmaceuticals, Llc | Pharmaceutical compositions for treating osteoarthritis |
| US20240358631A1 (en) * | 2023-04-26 | 2024-10-31 | ProVEDA Corporation | Topical formulations |
| US12133863B1 (en) * | 2023-06-07 | 2024-11-05 | King Saud University | Green synthesis of silver nanoparticles encapsulated in a nanostructured lipid carrier |
| CN120131482A (zh) * | 2025-02-14 | 2025-06-13 | 广州天然国度生物科技有限公司 | 一种护臀膏及其制备方法 |
Family Cites Families (46)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4405616A (en) * | 1975-06-19 | 1983-09-20 | Nelson Research & Development Company | Penetration enhancers for transdermal drug delivery of systemic agents |
| US4361585A (en) | 1979-05-03 | 1982-11-30 | Roy Edwards | Method of treatment to relieve pain in muscles or bones |
| CA1319613C (en) * | 1986-10-07 | 1993-06-29 | Gevork Minaskanian | Penetration enhancers for transdermal delivery of systemic agents |
| US4908387A (en) * | 1988-06-06 | 1990-03-13 | The Regents Of The University Of California | Use of beta2 antagonists in the treatment of inflammatory diseases, in particular, rheumatoid arthritis |
| SE9003665D0 (sv) * | 1990-11-16 | 1990-11-16 | Kabivitrum Ab | Morphine prodrugs |
| US5444076A (en) * | 1990-11-26 | 1995-08-22 | Roemmers S.A.I.C.F. | Pharmaceutical preparation for topical application |
| US5294438A (en) * | 1991-02-05 | 1994-03-15 | Minnesota Mining And Manufacturing Company | Lubricating and moisturizing shaving preparations |
| DE69221686T2 (de) * | 1991-03-01 | 1998-04-02 | Atherton Investments Ltd | Therapeutische und kosmetische zusammensetzungen zur hautbehandlung |
| US5336486A (en) * | 1991-03-28 | 1994-08-09 | Theratech, Inc. | Appetite control method |
| US5260313A (en) * | 1992-03-12 | 1993-11-09 | National Pain Institute, Inc. | Diagnosis and treatment of various neuralgias |
| US5401728A (en) * | 1992-04-02 | 1995-03-28 | Simon; John A. | Lecithin based topical liniment |
| DE4341139C1 (de) | 1993-12-02 | 1995-04-13 | Upmeyer Hans Juergen | Dimeticon zur Behandlung von Aphthen |
| US5773034A (en) * | 1994-05-09 | 1998-06-30 | Fortune Base Management, Ltd. | Cutaneous rejuvenating and healing product, method for its manufacture and uses thereof |
| US5560910A (en) * | 1994-08-26 | 1996-10-01 | Crandall; Wilson T. | Topical anti-inflammatory composition and method |
| US5654337A (en) * | 1995-03-24 | 1997-08-05 | II William Scott Snyder | Topical formulation for local delivery of a pharmaceutically active agent |
| JPH11507356A (ja) * | 1995-06-07 | 1999-06-29 | アブマックス，インコーポレイティド | 経口薬理化合物の生物有用性を高めるためのエッセンシャルオイルの利用 |
| US6479074B2 (en) * | 1996-10-24 | 2002-11-12 | Pharmaceutical Applications Associates Llc | Methods and transdermal compositions for pain relief |
| US6572880B2 (en) * | 1996-10-24 | 2003-06-03 | Pharmaceutical Applications Associates Llc | Methods and transdermal compositions for pain relief |
| US6413496B1 (en) * | 1996-12-04 | 2002-07-02 | Biogland Ireland (R&D) Limited | Pharmaceutical compositions and devices for their administration |
| US5976547A (en) * | 1997-04-22 | 1999-11-02 | Niblick Pharmaceuticals, Inc. | Analgesic and antiphlogistic compositions and therapeutic wrap for topical delivery |
| US6132762A (en) | 1997-05-05 | 2000-10-17 | Cristobal; Walter | Transcutaneous application of marijuana |
| US5824359A (en) * | 1997-06-30 | 1998-10-20 | Becton Dickinson And Company | Medical device lubricant containing lecithin |
| US5922332A (en) | 1997-09-17 | 1999-07-13 | Fossel; Eric T. | Topical delivery of arginine to overcome pain |
| US5885597A (en) | 1997-10-01 | 1999-03-23 | Medical Research Industries,Inc. | Topical composition for the relief of pain |
| MXPA00010103A (es) * | 1998-04-16 | 2002-08-06 | Natural Health Products Intern | Metodo para el tratamiento de asma. |
| CH689821A5 (it) * | 1998-06-22 | 1999-12-15 | Gecomwert Anstalt | Lozione tricologica ad uso topico. |
| EP1093348A4 (en) * | 1998-06-29 | 2003-07-16 | Pharmaceuticals Applic Asociat | TRANSDERMAL ANALGESIC COMPOSITIONS AND METHODS OF ADMINISTRATION |
| WO2000038732A1 (de) * | 1998-12-23 | 2000-07-06 | Esparma Gmbh | Hyaluronatlyase als penetrationsforderer in topischen mitteln |
| EP1165097B1 (en) * | 1999-02-01 | 2007-05-02 | Dermal Research Laboratories, Inc. | A pharmaceutical composition of complex carbohydrates and their use |
| EP1280537A2 (en) | 2000-05-12 | 2003-02-05 | Supratek Pharma, Inc. | Compositions of non-ionic block copolymers to treat autoimmune, proliferative, and inflammatory diseases and methods of use thereof |
| US20020169195A1 (en) * | 2001-01-26 | 2002-11-14 | George Kindness | Combination and method of treatment of cancer utilizing a COX-2 inhibitor and an HMG-CoA inhibitor and cystine to enhance glutathione |
| US6528076B2 (en) * | 2001-07-06 | 2003-03-04 | Magic Herb Corp. | Topical compositions and methods for treating pain |
| US6638981B2 (en) * | 2001-08-17 | 2003-10-28 | Epicept Corporation | Topical compositions and methods for treating pain |
| US6730667B2 (en) | 2001-11-26 | 2004-05-04 | William R. Deagle | Iontophoresis disc pain blocker |
| AU2004224332A1 (en) * | 2003-03-20 | 2004-10-07 | Imagenetix, Inc. | Esterified fatty acid composition |
| US7713440B2 (en) * | 2003-10-08 | 2010-05-11 | Lyotropic Therapeutics, Inc. | Stabilized uncoated particles of reversed liquid crystalline phase materials |
| WO2005041988A1 (en) | 2003-10-22 | 2005-05-12 | University Of Florida | Method and composition for pain amelioration |
| US20060099173A1 (en) * | 2003-10-24 | 2006-05-11 | Nancy Puglia | Topical skin care composition |
| US7029711B2 (en) | 2003-12-09 | 2006-04-18 | Shannon Lynn Farrell | Mixture of and method of making a trancutaneous pain relief composition |
| AU2006252616B2 (en) | 2005-05-31 | 2011-05-19 | Warsaw Orthopedic, Inc. | Compositions and methods for treating pain |
| US20080102107A1 (en) * | 2005-12-16 | 2008-05-01 | Valex Pharmaceuticals, Llc | Compositions and methods for transdermal joint pain therapy |
| WO2007089724A2 (en) * | 2006-01-31 | 2007-08-09 | Angiotech Biocoatings Corp. | Lubricious coatings |
| US9511016B2 (en) * | 2007-06-12 | 2016-12-06 | Epicentrx, Inc. | Topical composition for treating pain |
| US20090117059A1 (en) * | 2007-08-03 | 2009-05-07 | Oronsky Bryan T | Compositions and methods of use thereof, for the treatment of oral pain, comprising cloves or extracts thereof in combination with a steroid |
| US20090130048A1 (en) * | 2007-11-19 | 2009-05-21 | Oronsky Bryan Todd | Topical Composition for Treating Pain |
| WO2010009056A2 (en) * | 2008-07-14 | 2010-01-21 | Comgenrx, Inc. | Pain relieving patch |
-
2007
- 2007-09-06 US US11/851,241 patent/US9511016B2/en active Active
-
2008
- 2008-06-11 JP JP2010512189A patent/JP2010531298A/ja active Pending
- 2008-06-11 WO PCT/US2008/007354 patent/WO2008156646A1/en not_active Ceased
- 2008-06-11 AU AU2008266971A patent/AU2008266971B2/en active Active
- 2008-06-11 EP EP08768401A patent/EP2164476A1/en not_active Withdrawn
- 2008-06-11 CN CN200880100902A patent/CN101842090A/zh active Pending
- 2008-06-12 US US12/138,304 patent/US20080311218A1/en not_active Abandoned
- 2008-06-12 US US12/138,300 patent/US20080311217A1/en not_active Abandoned
- 2008-06-16 US US12/140,080 patent/US20080312583A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010531298A5 (cg-RX-API-DMAC7.html) | ||
| US9511016B2 (en) | Topical composition for treating pain | |
| US20090130182A1 (en) | Topical compositions for treating pain | |
| US20220142953A1 (en) | Lidocaine patch and methods of use thereof | |
| JP2009519940A (ja) | 皮膚科学的状態を処置するための組成物および方法 | |
| RU2095060C1 (ru) | Композиция, обладающая аналгетической или противовоспалительной активностью, способ аналгезии или лечения аллергических заболеваний | |
| JP2009524586A (ja) | 疼痛を皮膚処置するための組成物および方法 | |
| US20200246408A1 (en) | Compositions for relieving pain with malkangni oil and cypriol oil as active ingredients and method of topical administration of the same | |
| CA2940057C (en) | Transdermal composition for treating pain | |
| TW201912156A (zh) | 組成物在製備治療睡眠障礙的藥劑的用途 | |
| CA1169774A (en) | Medication having penetration through cutaneous surfaces into articular and muscular areas | |
| Cantisani et al. | New patents on topical anesthetics | |
| CA2422531C (en) | Topical analgesic compositions containing aliphatic polyamines and methods of using same | |
| JPH11116470A (ja) | イデベノン含有経皮投与製剤 | |
| AU2007280440A1 (en) | Treatment and prevention of excessive scarring | |
| WO2018147790A1 (en) | Anaesthetic composition comprising ropivacaine, prilocaine and lidocaine | |
| KR100347883B1 (ko) | 국소마취제를 함유한 약용겔제 조성물 | |
| US20250186365A1 (en) | Combination of antispasmodic and osmotic agents for topical products and method of use thereof | |
| JP2005089345A (ja) | 虫刺され治療薬 | |
| RU2287997C1 (ru) | Состав для лечения воспалительных заболеваний | |
| EP1891945A1 (en) | Treatment and prevention of excessive scarring |